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KEY MESSAGES 51
The ability of neutrophils to impair Aspergillus hyphal growth is altered during recovery in 52 allogenic hematopoietic stem cell transplant recipients. 53
The administration of calcineurin inhibitors seems to play an important role in this impair-54 ment, in stark contrast to the classical view of these inhibitors as affecting only adaptive im-55 munity. 56
57
CAPSULE SUMMARY 58
In allogenic hematopoietic stem cell transplant recipients, fungal innate immunity driven by 59 neutrophils is altered during the first months of the graft, in relation with the use of calcineu-60 rin inhibitors. 
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proximately 15-20 µm can be considered either as germinating conidia or as small hyphae. 125
The medium was then changed to RPMI without FCS and the isolated neutrophils were added 126 to the wells at different effector:target ratios in triplicate. In others experiments, neutrophils 127 were added directly to resting conidia. The plates were incubated overnight at 37°C with 5% 128 CO 2 then washed with purified water. Uvitex (1% w/v), a fluorescent marker of chitin (similar 129 to calcofluor, which has already been used to assess fungal biomass 8 ) was added to the final 130 dilution. Finally, plates were read using a Flexstation analyzer with excitation at 350 nm and 131 emission at 435 nm. For a given effector:target ratio, the fungal growth was determined as the 132 ratio of the fluorescence intensity of the well containing neutrophils mixed with Aspergillus to 133 that of the well containing Aspergillus only. The percentage of inhibition was defined as 100 134 minus the percent of fungal growth. 135
Surface molecule expression of neutrophils. Five-hundred-microliter whole-blood samples 136
were stimulated with either 10 6 Aspergillus conidia (resting or germinating), 5 ng/mL bacteri-137 al lipopolysaccharide (LPS) (Sigma Aldrich) or PBS as control for 45 minutes at 37°C. Neu-138 trophils were stained with an anti-human CD11b (or integrin alpha M) antibody (Dako), an 139 anti-human CD62L (or L-selectin) antibody (Becton Dickinson) and/or an anti-human CD66 140 (or carcinoembryonic antigen) antibody (Becton Dickinson) before cytometry analysis. TLR 141 and dectin expression were assessed using anti-TLR2, anti-TLR4 and anti-dectin-1 antibodies 142 (RD Systems). Cytometry was performed on a Gallios flow cytometer and results were ana-143 lyzed using Kaluza software (Beckman Coulter) . 144
Measurement of neutrophil oxidative burst. Neutrophils contained in 500 µL heparinized 145 whole-blood samples were incubated with hydroethidine (Sigma Aldrich) (final concentration 146 1.5 µg/mL) for 15 minutes at 37°C, then stimulated with either 10 6 Aspergillus conidia (rest-147 ing or germinating), 5 ng/mL LPS or PBS as control for 45 minutes at 37°C. Then PMA (finalM A N U S C R I P T The majority of patients (86.5%) were transplanted with a matched related donor. Condition-168 ing regimens were mainly busulfan-based with reduced intensity (54.1%) or myeloablative 169 (29.7%). All patients received GvHD prophylaxis involving a calcineurin inhibitor-based reg-170 imen plus other drugs depending on the type of graft and conditioning. 171
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Neutrophils were collected from patients in the first month (recovery from neutropenia) and at 172 two, six and ten months post-HSCT. Recovery from neutropenia ("recovery" hereafter) wasM A N U S C R I P T
defined as the day where the neutrophil count became >500/mm3 (although for one patientcorticosteroid therapy. Due to patient death or loss to follow-up, 10-month samples were 177 available for only 10 patients. The characteristics of blood samples and immunosuppressive 178 drugs regimens at one, two, six and ten months post-HSCT are presented in Table 2 . Only 179 donor-derived cells were detectable for all included recipients after approximatively two 180 months post-transplant (data not shown). 181
182
Neutrophil surface molecule expression after HSCT 183
The surface expression of CD11b (also known as integrin alpha M), CD62L (or L-selectin) 184 and CD66 was evaluated at the basal level and following stimulation by resting/germinating 185 conidia or LPS. In association with the β 2 integrin (or CD18), CD11b forms the heterodimeric 186 integrin macrophage-1 antigen involved in the adhesion and migration of leukocytes. CD11b 187 is expressed at the surface of neutrophils after degranulation as it is contained in secondary 188 and tertiary neutrophil granules. CD62L is involved in transient tethering of the neutrophils to 189 the endothelial surface. The shedding of CD62L marks an activation of the neutrophils. CD66 190 is specific to secondary granules 10 . Surface expression of the major pattern recognition recep-191 tors TLR-2, TLR-4 and dectin-1 were also assessed by flow cytometry. Neutrophils were 192 found to be activated in only a limited manner by resting conidia but they were strongly acti-193 vated by germinating conidia, as evidenced by an increase in CD11b and CD66 expression 194 and a decrease in CD62L expression ( Figure 1a and data not shown). As tested, LPS induced 195 high activation. There were however no observed differences over time. It is also noteworthy 196 that no differences were observed between donors and patients during recovery except as 197 concerns the expression of CD66, which was higher after the graft (Figure 1 a- Interestingly, there were no differences concerning the ability of neutrophils to inhibit the 216 development of resting conidia (data not shown). Of note, no correlations were observed be-217 tween, on one hand, the period between engraftment and sampling, and on the other, the per-218 centage of inhibition. There was also no link between the absolute neutrophil count at the 219 time of sampling and the ability of neutrophils to inhibit Aspergillus growth (data not shown). 220 M A N U S C R I P T
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Effect of calcineurin inhibitors on neutrophil impairment of Aspergillus hyphal growth. 224
During the study, some patients in recovery had neutrophils that were as effective as controls 225 at inhibiting Aspergillus growth. This was not related to time to engraftment, type of graft, 226 type of conditioning, or absolute neutrophil count in blood. But interestingly, we found that 227 these patients had low plasma calcineurin inhibitor trough concentrations. Indeed, these 228 treatments are difficult to balance and therefore regularly monitored. Considering this, we 229 compared the neutrophils of patients with low plasma calcineurin inhibitor trough concentra-230 tions (i.e. <120 ng/mL for cyclosporine and <6 ng/mL for tacrolimus) to those of patients with 231 normal trough concentrations (i.e. >150 ng/mL and >10 ng/mL) for Aspergillus inhibition and 232 found that this latter was significantly greater in patients with low plasma concentrations 233 ( Figure 3b ). To strengthen the hypothesis that the observed effect was due to a pharmacologi-236 cal effect and not a generic effect of recovery, which is a very complex phenomenon, we per-237 formed growth inhibition tests using neutrophils from patients recovering from autologous 238 stem cell transplantation, where calcineurin inhibitors are not administered. In this setting, we 239 found no defects in the ability of neutrophils to impair Aspergillus growth ( Figure 2a) . 240
We also performed in vitro experiments to further assess the hypothesis that calcineurin inhib-241 itors were correlated with reduced neutrophil inhibition. When blood sampled from healthy 242 donors was incubated with cyclosporine at 37°C for 2 hours, the subsequently isolated neu-243 trophils showed diminished activity in terms of Aspergillus growth inhibition, in comparison 244 to untreated controls ( Figure 4) . Cyclosporine thus appears to impair neutrophil activity 245 against A. fumigatus hyphae. 246
Alterations to NETs production in early post-HSCT period. 248 M A N U S C R I P T
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Neutrophils can exert their function through different mechanisms including phagocytosis, 249 ROS production, degranulation and NETs production. As discussed above, neither ROS pro-250 duction nor degranulation (investigated by CD11b and CD66 surface expression) were altered 251 in the present study. Neutrophils cannot phagocytize hyphae due to their size and support ad-252 hesion but it has been shown that they produce NETs in contact with Aspergillus consequent-253 ly inhibiting its growth 11, 12 . We thus investigated the production of NETs by neutrophils and 254 their effects on fungal growth in both HSCT patients and healthy donors. 255
Neutrophils were co-cultured with Aspergillus for three hours and NETs production was visu-256 alized using Sytox green. In accordance with the results presented above, Aspergillus growth 257
as assessed by hyphal length measurement during the three-hour culture was greater in pa-258 The evaluation of neutrophil action against Aspergillus showed significant variations over 267 time (Figure 6 ). Due to their general and previously reported effect on immunity against As-268 pergillus 13, 14 , the administration of corticoids increased the impairment of neutrophil activity 269 against hyphae. Importantly, in the 10 patients studied 10 months after the HSCT and for 270 whom immunosuppressive therapies were stopped or considerably reduced, the percentage of 271
Aspergillus growth inhibition was restored to the control (donor) level. These results indicate 272 first that the effect of calcineurin inhibitors may add to other immunosuppressive effects, and 273 M A N U S C R I P T
second, that these effects are not permanent, at least when treatment is stopped or decreased 274 within some number of months. 275 276
DISCUSSION. 277
The few studies that have focused on the behavior of neutrophils following HSCT provide a 278 range of results suggesting moderate to no alterations in oxidative burst or antimicrobial ac-279 tivity 15 . For the present study, we aimed at evaluating neutrophil function in HSCT recipients 280 compared to that in healthy donors as concerns the major human pathogen mold Aspergillus. 281
We found that oxidative burst and surface molecule expression at basal levels and following 282 stimulation did not vary significantly over time, with the exceptions of CD66, which was 283 more highly expressed during recovery, and TLR2, which was slightly less expressed. How-284 ever, our results show that the recovery period is associated with a dramatic decrease in the 285 ability of neutrophils to inhibit Aspergillus hyphae growth, and that the use of calcineurin 286 inhibitors may play a large role in this impairment. It is well known that HSCT recipients are 287 particularly at risk for invasive aspergillosis, not only during the neutropenia period but also 288 after engraftment. It should be acknowledged however that neutrophil recovery is not the 289 most at-risk period since antifungal prophylaxis is now widely used, and furthermore that the 290 use of a calcineurin inhibitor is probable not singly sufficient to trigger invasive aspergillosis 291 although cases of aspergillosis in patients receiving cyclosporine have been reported 16 . Nev-292 ertheless, aspergillosis breakthrough in patients receiving antifungals is not rare 17, 18 and the 293 assessment of the ability of neutrophils to correctly impair (or not) Aspergillus growth could 294 be used to evaluate the risk of invasive aspergillosis in at-risk patients and thus contribute to 295 reducing the fungal risk. Nonetheless, calcineurin inhibitors do appear to add to other ac-296 quired or potential innate immune deficiencies that, together, favor the appearance of fungal 297 disease, which can occur any time after HSCT. Indeed, approximately 20% of invasive mold 298 Thus, they not only inhibit the phosphatase activity of calcineurin but also the peptidyl-prolyl 323 M A N U S C R I P T 30 . We underline however that those two studies used different agents to induce NETo-335 sis: interleukin-8 for the former and LPS for the latter. In our work, we found that neutrophils 336 sampled from patients in recovery were less efficient at inhibiting Aspergillus growth than 337 those collected from healthy donors. ROS production was not impaired during recovery and 338 no correlation was observed between the percentage of inhibition and the level of oxidative 339 burst following stimulation by germinating conidia (data not shown). In contrast, Stuehler et 340 al reported recently that the ROS production of neutrophils collected from HSCT patients and 341 stimulated by Aspergillus was altered 30 days after the graft 31 . Interestingly however, their 342 results also indicate that the percentage of fungal damage mediated by neutrophils was de-343 creased in HSCT patients compared to controls, even in patients with normal ROS production 344 31 . In accordance with that, it has been shown that cyclosporine does not impair ROS produc-345 tion 23 . Finally, in our microscopy experiments, we observed that in co-cultures with Aspergil-346 lus, neutrophils sampled from patients in recovery produced less NETs than those sampled 347 from healthy donors, with a higher rate of fungal growth. However, rather than a specific efM A N U S C R I P T
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fect on NETosis, it seems that this diminished NET production is more generally a reflection 349 of a lower neutrophil death rate. The implication of calcineurin in cell death was first reported 350 long ago 32 
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We thank all patients and healthcare providers and express our gratitude to Coralie Pannelier, tor trough levels (i.e. >150 ng/mL for cyclosporine and >10 ng/mL for tacrolimus) are less 549 capable of inhibiting Aspergillus growth than those retrieved from patients with low trough 550 levels (i.e. <120 ng/mL for cyclosporine and <6 ng/mL for tacrolimus). Long horizontal bars 551 indicate the mean with short bars for the standard error of the mean. 
